abstract |
The present invention provides a method of treating motor urge urinary incontinence in a mammal which comprises administering an effective amount of a competitive NMDA antagonist, such as (3S,4aR,6S,8aR)-decahydro-6-phosphonomethyl)-3-isoquinolinecarboxylic acid, (3S,4aR,6S,8aR)-decahydro-6-[1(2)H-tetrazole-5-ylmethyl]-3-isoquinolinecarboxylic acid, or (2R,4S)-cis-4-[(1(2)H-tetrazole-5-yl)methyl]-2-piperidinecarboxylic acid. |